MedTrace Logo

Clinical Investigation for Evaluating the Safety and Efficacy of JTM102 to Mid Face Volume Deficiency

NCT07265778 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 149

Last updated 2025-12-05

No results posted yet for this study

Summary

This study is clinical investigation for evaluating safety and efficacy of JTM102 on temporary correction of mid-face volume deficiency

Conditions

  • Mid Face Volume Deficit

Interventions

DEVICE

JTM102

Sodium Hyaluronate 20mg/ml Lidocaine Hydrochloride 03.%

DEVICE

Juvederm VOLUMA with Lidocaine

Sodium Hyaluronate 20mg/ml Lidocaine Hydrochloride 0.3%

Sponsors & Collaborators

  • Jetema Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-22
Primary Completion
2026-04-30
Completion
2026-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07265778 on ClinicalTrials.gov